These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 4029482
21. Properties of dopamine agonist and antagonist binding sites in mammalian retina. Makman MH, Dvorkin B, Horowitz SG, Thal LJ. Brain Res; 1980 Aug 04; 194(2):403-18. PubMed ID: 6770965 [Abstract] [Full Text] [Related]
22. Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine. Riffee WH, Wilcox RE, Vaughn DM, Smith RV. Psychopharmacology (Berl); 1982 Aug 04; 77(2):146-9. PubMed ID: 6812131 [Abstract] [Full Text] [Related]
23. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes. Hamblin MW, Leff SE, Creese I. Biochem Pharmacol; 1984 Mar 15; 33(6):877-87. PubMed ID: 6712712 [Abstract] [Full Text] [Related]
24. Cataleptogenic doses of morphine suppress 3H-spiroperidol binding to striatal membranes. Golembiowska-Nikitin K, Pilc A, Vetulani J. Naunyn Schmiedebergs Arch Pharmacol; 1982 May 15; 319(2):140-1. PubMed ID: 7202125 [Abstract] [Full Text] [Related]
26. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone. Lazareno S, Nahorski SR. Eur J Pharmacol; 1982 Jul 09; 81(2):273-85. PubMed ID: 7117377 [Abstract] [Full Text] [Related]
30. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems. Robertson HA. Brain Res; 1983 May 09; 267(1):179-82. PubMed ID: 6860944 [Abstract] [Full Text] [Related]
31. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding. Creese I, Snyder SH. Eur J Pharmacol; 1979 Jun 15; 56(3):277-81. PubMed ID: 38973 [Abstract] [Full Text] [Related]
33. [3H]Spiperone binding sites in brain: autoradiographic localization of multiple receptors. Palacios JM, Niehoff DL, Kuhar MJ. Brain Res; 1981 Jun 01; 213(2):277-89. PubMed ID: 7248759 [Abstract] [Full Text] [Related]
34. Reduction of 3H-spiroperidol binding in rat striatum and frontal cortex by chronic amphetamine: dose response, time course and role of sustained dopamine release. Nielsen EB, Nielsen M, Braestrup C. Psychopharmacology (Berl); 1983 Jun 01; 81(1):81-5. PubMed ID: 6415736 [Abstract] [Full Text] [Related]
36. Increase in in vivo (3H) spiperone binding in the rat hippocampal formation and striatum after repeated treatment with haloperidol. Bischoff S. Experientia; 1981 Jun 01; 37(9):1008-9. PubMed ID: 7297644 [Abstract] [Full Text] [Related]
37. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum. Waddington JL, Cross AJ, Longden A, Owen F, Poulter M. Eur J Pharmacol; 1979 Oct 01; 58(3):341-2. PubMed ID: 510367 [No Abstract] [Full Text] [Related]
38. Effects of estrogens on the characteristics of [3H]spiroperidol and [3H]RU24213 binding in rat anterior pituitary gland and brain. Di Paolo T, Carmichael R, Labrie F, Raynaud JP. Mol Cell Endocrinol; 1979 Nov 01; 16(2):99-112. PubMed ID: 116893 [Abstract] [Full Text] [Related]